CorMedix Inc.
DE ˙ DB ˙ US21900C3088
7,15 € ↑0,26 (3,77%)
2026-06-05
DEL PRIS
SecurityDE:19KA / CorMedix Inc.
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership277,784 shares
Latest Disclosed Value $ 1,886,153
Ameriprise Financial Inc reports 0.45% decrease in ownership of 19KA / CorMedix Inc.

On May 15, 2026 - Ameriprise Financial Inc filed a 13F-HR form disclosing ownership of 277,784 shares of CorMedix Inc. (DE:19KA) valued at $1,555,590 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 279,026 shares of CorMedix Inc.. This represents a change in shares of -0.45% during the quarter. The current value of the position is $1,985,600 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORMEDIX COM 21900C308 277,784 -1,242 -0.45 1,886 -41.88 0.0001
2026-02-17 2025-12-31 13F CORMEDIX COM 21900C308 279,026 42,616 18.03 3,245 18.04 0.0007
2025-11-14 2025-09-30 13F CORMEDIX COM 21900C308 236,410 58,688 33.02 2,749 25.58 0.0006
2025-08-14 2025-06-30 13F CORMEDIX COM 21900C308 177,722 62,322 54.01 2,190 208.31 0.0005
2025-05-14 2025-03-31 13F CORMEDIX COM 21900C308 115,400 102,644 804.67 711 589.32 0.0002
2025-02-14 2024-12-31 13F CORMEDIX COM 21900C308 12,756 12,756 103 0.0000
2024-11-14 2024-09-30 13F CORMEDIX COM 21900C308 0 -11,697 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CORMEDIX COM 21900C308 11,697 11,697 51 0.0000
2024-02-14 2023-12-31 13F CORMEDIX COM 21900C308 0 -10,700 -100.00 0 -100.00
2023-11-14 2023-09-30 13F CORMEDIX COM 21900C308 10,700 10,700 40 0.0000
2023-05-22 2023-03-31 13F/A-1 CORMEDIX COM 21900C308 0 -17,800 -100.00 0 -100.00
2023-05-15 2023-03-31 13F CORMEDIX COM 21900C308 0 -17,800 0
2023-02-14 2022-12-31 13F CORMEDIX COM 21900C308 17,800 -9,700 -35.27 75 -3.85 0.0000
2022-11-14 2022-09-30 13F CORMEDIX COM 21900C308 27,500 -633 -2.25 78 -30.97 0.0000
2022-08-15 2022-06-30 13F CORMEDIX COM 21900C308 28,133 -6,500 -18.77 113 -40.53 0.0000
2022-05-16 2022-03-31 13F CORMEDIX COM 21900C308 34,633 0 0.00 190 20.25 0.0001
2022-02-14 2021-12-31 13F CORMEDIX COM 21900C308 34,633 -15,187 -30.48 158 -31.60 0.0000
2021-11-15 2021-09-30 13F CORMEDIX COM 21900C308 49,820 -7,570 -13.19 231 -41.37 0.0001
2021-08-16 2021-06-30 13F CORMEDIX COM 21900C308 57,390 3,195 5.90 394 -27.31 0.0001
2021-05-17 2021-03-31 13F CORMEDIX COM 21900C308 54,195 32,805 153.37 542 258.94 0.0002
2021-02-12 2020-12-31 13F CORMEDIX COM 21900C308 21,390 21,390 151 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.